TruthArchive.ai - Related Video Feed

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. By introducing Wolbachia bacteria into the mosquitoes, their ability to transmit diseases like dengue is stopped. The process involves releasing Wolbachia-infected mosquitoes into the wild population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio. The mosquitoes are fed blood and then either packaged as eggs or released as adults into the field. With over half the world's population at risk of these diseases, the goal is to scale and deliver this solution to communities in need.

We are using genetically modified organisms in vaccines to reduce the world's population by 10-15% through improved healthcare and reproductive services. The current global population is 6.8 billion, projected to reach 9 billion. The focus is on developing new vaccines to achieve this goal.

Hi. I'm Scott O'Neill here in Medellin, Colombia today, and I'm at the world's biggest mosquito factory for the World Mosquito Program. We're making in here 30,000,000 mosquitoes a week. We've been able to bring the solution of Wolbachia mosquitoes to the city. When this bacteria called Wolbachia gets introduced into the mosquito, it stops their ability to transmit dengue. We release mosquitoes that have Wolbachia, and then they go and mate, and Wolbachia gets passed into the wild mosquito population. If we're going to control these diseases in all the tropical cities of the world, it's gonna require a lot of mosquitoes. The mosquito life cycle starts with the egg, and in this room, we've got a lot of eggs. Each one of these strips, these tiny black dots are up to 10,000 mosquito eggs.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to stop the transmission of diseases like dengue, Zika, and chikungunya. The factory starts with mosquito eggs, which hatch into larvae and then pupae. The males and females are sorted, with more females being desired. The adult mosquitoes are either packaged as eggs in gelatin capsules or released directly into the field. The goal is to scale this solution and deliver it to communities worldwide that are affected by these diseases.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to prevent the transmission of diseases like dengue, Zika, and chikungunya. The process involves introducing Wolbachia into the mosquitoes, which then pass it on to the wild mosquito population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio in the cages. The mosquitoes are fed blood and can be released into the field either as eggs or as adults. The program aims to scale and deliver this solution to communities worldwide.

We are in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million mosquitoes a week to combat diseases like dengue and Zika by introducing Wolbachia bacteria into the mosquito population. The process starts with eggs, then larvae, pupae, and finally adult mosquitoes. We sort males from females to control the sex ratio. The mosquitoes are fed blood and then released into the field to mate and spread Wolbachia.

I'm Scott O'Neill in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million Wolbachia mosquitoes weekly to combat diseases like dengue. The Wolbachia bacteria stops mosquitoes from transmitting dengue. We breed mosquitoes from eggs to adults, sorting males and females to control the sex ratio. The females are released into the field after feeding on blood. Our goal is to reduce mosquito-borne diseases in tropical cities worldwide.

A billion genetically modified mosquitoes are being released in the Florida Keys to combat diseases like dengue, yellow fever, and Zika. This is the first time such mosquitoes are being released in the US. The British biotech company, Oxitec, obtained permission from the EPA to release them across 6,000 acres in Florida and Texas. However, a 2019 Yale University study warned that this plan could have unintended consequences. It suggested that the release of these mosquitoes could lead to the creation of hybrid mosquito babies that are more resistant to insecticides, potentially worsening the spread of diseases. The potential risks raise concerns about the success of this initiative.

People eating too much meat is a problem for the planet, but many are unwilling to give it up due to weakness of will. One solution could be using human engineering to make people intolerant to certain types of meat, similar to how some are intolerant to milk or crayfish. An example of this is the long star tick, which can make people allergic to meat if it bites them. Through human engineering, we have the potential to address significant global issues.

We discovered that Ivermectin can kill COVID-19 in primate cells. A single dose of the drug stopped the virus from replicating within 48 hours. Human trials are on the horizon, as the drug has been safely used for decades. Repurposing existing drugs like Ivermectin can speed up development by utilizing known safety profiles and administration methods. We are working on determining if these benefits can translate to treating COVID-19 in humans.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. The goal is to combat diseases like dengue, Zika, and chikungunya by introducing a bacteria called Wolbachia into the mosquitoes, which stops their ability to transmit dengue. The factory houses millions of mosquito eggs, which hatch into larvae and eventually become adult mosquitoes. The males and females are sorted to manipulate the sex ratio in the cages. The mosquitoes are fed blood and then released into the field once they are fully grown.

Malaria eradication is challenging, but gene drive technology could change the genetics of mosquitoes to help achieve this goal. Mosquitoes can be genetically modified to act as "flying syringes" that deliver malaria vaccines when they bite humans. However, there are concerns about the potential risks of spreading malaria and the ethical implications of genetically modifying mosquitoes without informed consent. Despite these concerns, the development of new tools and technologies is crucial for malaria eradication.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week. This is done to combat diseases like dengue, Zika, and chikungunya. By introducing a bacteria called Wolbachia into the mosquitoes, their ability to transmit dengue is stopped. The factory houses millions of mosquito eggs, which hatch into larvae and eventually become adults. The males and females are sorted, with more females being desired. The adult mosquitoes are then released into the field. The mosquitoes are fed blood to sustain them. This massive production of mosquitoes is necessary to control diseases in tropical cities worldwide.

In 1956, the US military released Aedes aegypti mosquitoes infected with the malaria virus in Savannah, Georgia as part of Operation Big Buzz. Now, the military is testing genetically modified mosquitoes to deliver vaccinations, funded by the Bill and Melinda Gates Foundation. However, some residents are concerned about the potential risks and lack of scientific investigation. Similar efforts are being made in Houston to combat the Zika virus. Meanwhile, Oxford University has developed a vaccine that could reduce malaria deaths by 70% by 2030. In Fresno, California, a project is releasing a million mosquitoes per week to reduce the population. In Medellin, Colombia, Wolbachia-infected mosquitoes are being released to control diseases like dengue.

In this video, the speaker discusses the challenges of eradicating malaria and the potential use of genetically modified mosquitoes to deliver vaccines. They express concerns about the spread of malaria if the genetic modification fails and question the ethical implications of releasing modified mosquitoes without informed consent. Another speaker highlights the importance of considering climate change and its impact on the geographic range of disease-carrying mosquitoes. They emphasize the need to prevent, prepare for, and respond to emerging pathogens, using the systems and tools developed for COVID-19 as examples. The speaker also mentions the efforts made by countries to strengthen their healthcare systems for various diseases.

This precision tool introduces a protein RNA complex into cells or tissues to correct mutations. The complex can be injected into fertilized eggs, such as those of a mouse. In an experiment targeting the gene for black coat color, edited eggs implanted in a female mouse resulted in mostly white pups. These mice have a single genetic change in every cell, giving rise to the white coat color, but are otherwise normal. This type of experiment used to take at least a year; now it can be done in a few weeks. The technology has seen exponential growth in publications and is being used for targeted genetic changes in plants, fungi, and animals important agriculturally or as pets. It's also being used to make changes in stem cells and in animal models of human disease, with the possibility of making changes in humans in the future.

CRISPR is a molecular tool that allows for precise genetic editing. Since its introduction in 2012, it has been used to modify various species, including potentially spreading alterations through wild organisms. Malaria is a highly destructive disease, causing the death of 400,000 children annually. Scientists propose using CRISPR to disable or eliminate the mosquito species that transmit malaria, as it is a more effective solution than widespread DDT spraying. Despite potential risks, the severity of malaria outweighs any possible negative consequences, making it a worthwhile endeavor.

The speakers discussed the possibility of using gene editing to solve hair loss and enhance physical attributes. They stated that delivering gene therapies to specific cells is improving, with sickle cell anemia research being the most advanced, using a single CRISPR knockout. This could potentially be done on someone already born, though it's easier at the embryo stage. One speaker envisions a future where gene editing allows people to alter their appearance and intelligence, referencing plastic surgery trends like South Korean eye surgery and GLP-1s. The other speaker likened this to a "eugenics world" and "playing God."

We conducted a study in Senegal to see how Ivermectin, given to people for river blindness, affected mosquitoes that transmit malaria. By catching mosquitoes before and after treatment, we found that the drug killed most adult mosquitoes, particularly the ones that transmit malaria. Although the total number of mosquitoes didn't decrease significantly, the drug effectively eliminated the old females responsible for spreading malaria.

Researchers at the Bill Gates Foundation-backed Leiden University Medical Center are developing genetically modified mosquitoes to deliver malaria vaccines. A recent study showed that 8 out of 9 participants who received bites from one type of modified mosquito were protected against malaria, while those in the placebo group received no protection. Despite safety concerns and ethical issues regarding informed consent, the research continues, with plans for larger trials and potential applications for other diseases. Meanwhile, an Australian regulatory body is reviewing an application to release genetically modified mosquitoes to combat dengue fever. The implications of using insects as vaccine carriers raise significant ethical questions, and there are ongoing calls for accountability regarding these experiments.